MCRB
Seres Therapeutics Inc
2.90$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.50 | -2.73 | -5.32 | -34.71 | 22.04 | -37.34 | -30.85 | -27.02 | -23.46 | 1.46 | -42.34 | -18.34 | -19.13 | 0.13 | |
| 0.01 | 0.05 | 0.10 | 0.62 | 2.11 | 3.59 | 3.86 | 2.68 | 1.65 | 1.30 | 1.23 | 0.98 | 0.70 | 0.47 | |
| 0.01 | 0.11 | 1.06 | 8.24 | 8.46 | 8.58 | 8.17 | 2.95 | 2.21 | 4.41 | 4.72 | 5.33 | 2.70 | 1.22 | |
| – | – | 1.99 | 8.56 | 8.46 | 8.59 | 8.17 | 3.08 | 2.21 | 5.30 | 4.72 | – | – | – | |
| 0.08 | 0.23 | 1.17 | 2.67 | 57.63 | -5.22 | 5.79 | -8.69 | -5.81 | 9.06 | -3.40 | -9.21 | -8.43 | -3.13 | |
| 0.15 | 0.09 | 0.51 | 3.71 | 10.79 | 2.31 | 0.95 | 0.35 | 0.15 | 2.09 | 1.82 | 1.25 | 0.05 | 0.03 | |
| -0.16 | -0.09 | -0.57 | -116.55 | -32.85 | 28.18 | 55.13 | -10.77 | -39.83 | 13.98 | 15.25 | 1.65 | 18.31 | 0.00 | |
| – | – | – | 0.22 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | |
| – | – | 0.01 | -0.02 | 1.07 | -0.02 | -0.10 | 21.52 | 64.83 | 0.46 | 18.40 | – | – | – | |
| – | – | 0.82 | -2.21 | 12.55 | 12.36 | 12.27 | 8.68 | -0.24 | -0.21 | 4.76 | 7.89 | -16.46 | 0.00 | |
| 4.84 | 0.48 | 63.67 | 117.05 | 1.07 | 0.04 | 0.13 | 30.44 | 76.06 | 0.26 | 23.98 | 11.20 | -11.63 | 1.57 | |
| 3.18 | -2.34 | 57.78 | -34.21 | -9.73 | -9.12 | 24.41 | -7.35 | 12.76 | 15.69 | -3.11 | -5.48 | -12.44 | 1.69 | |
| -1.65 | -2.82 | -5.83 | -38.42 | 11.26 | -39.65 | -31.80 | -27.37 | -23.61 | -0.63 | -44.16 | -19.58 | -19.17 | 0.10 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.